These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34690289)

  • 1. An Evanishing Thyroid During Immune Checkpoint Inhibitor Therapy.
    Cuzzocrea M; Paone G; Ceriani L; Giovanella L
    Clin Nucl Med; 2022 Mar; 47(3):253-254. PubMed ID: 34690289
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Eshghi N; Garland LL; Nia E; Betancourt R; Krupinski E; Kuo PH
    J Nucl Med Technol; 2018 Sep; 46(3):260-264. PubMed ID: 29599403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency.
    Katakura Y; Kimura T; Kusano T; Tatsumi F; Iwamoto Y; Sanada J; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
    Front Endocrinol (Lausanne); 2021; 12():722586. PubMed ID: 34712202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT.
    Nawwar AA; Searle J; Lyburn ID
    Clin Nucl Med; 2021 Feb; 46(2):e121-e122. PubMed ID: 32969909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive loss of the thyroid tissue integrity visualised by serial CT scans.
    Koyama H; Hattori R; Sagawa H; Tanaka T
    BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36109095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
    Kotwal A; Kottschade L; Ryder M
    Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
    [No Abstract]   [Full Text] [Related]  

  • 8. RAPID EVOLUTION OF THYROID DYSFUNCTION IN PATIENTS TREATED WITH NIVOLUMAB.
    O'Malley G; Lee HJ; Parekh S; Galsky MD; Smith CB; Friedlander P; Yanagisawa RT; Gallagher EJ
    Endocr Pract; 2017 Oct; 23(10):1223-1231. PubMed ID: 29045188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.
    Yamada H; Okajima F; Onda T; Fujimori S; Emoto N; Sugihara H
    BMC Endocr Disord; 2020 Aug; 20(1):132. PubMed ID: 32847555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
    Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
    BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.
    Mosaferi T; Tsai K; Sovich S; Wilhalme H; Kathuria-Prakash N; Praw SS; Drakaki A; Angell TE; Lechner MG
    Thyroid; 2022 May; 32(5):496-504. PubMed ID: 35199588
    [No Abstract]   [Full Text] [Related]  

  • 12. Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CT.
    Hotta M; Naka G; Minamimoto R; Takeda Y; Hojo M
    Clin Nucl Med; 2020 Nov; 45(11):910-912. PubMed ID: 32701815
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hotta M; Sonni I; Benz MR; Gafita A; Bahri S; Shuch BM; Yu R; Liu ST; Czernin J; Calais J
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3736-3737. PubMed ID: 33914106
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma.
    Amrane K; Le Goupil D; Quere G; Delcroix O; Gouva S; Schick U; Salaun PY; Abgral R; Alavi Z; Keromnes N; Querellou S
    Medicine (Baltimore); 2019 Jul; 98(29):e16417. PubMed ID: 31335691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoassay Interference on Thyroid Function Tests During Treatment with Nivolumab.
    Paragliola RM; Corsello A; Papi G; Melfa E; Urbani A; Pontecorvi A; Corsello SM; Carrozza C
    Thyroid; 2020 Jul; 30(7):1091-1094. PubMed ID: 32122271
    [No Abstract]   [Full Text] [Related]  

  • 16. Progression of Focal to Diffuse Thyroid Uptake Detected by 18F-FDG PET/CT: Malignant Metastatic Disease or Benign Thyroiditis?
    Thuillier P; Crouzeix G; Descourt R; Salaun PY; Abgral R
    Clin Nucl Med; 2018 Sep; 43(9):e310-e311. PubMed ID: 29939952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab.
    de Filette J; Jansen Y; Schreuer M; Everaert H; Velkeniers B; Neyns B; Bravenboer B
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4431-4439. PubMed ID: 27571185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of positive antithyroid antibodies is observed in patients with thyroid dysfunction related to immune check point inhibitors.
    Mazarico I; Capel I; Giménez-Palop O; Albert L; Berges I; Luchtenberg F; García Y; Fernández-Morales LA; De Pedro VJ; Caixàs A; Rigla M
    J Endocrinol Invest; 2019 Dec; 42(12):1443-1450. PubMed ID: 31093955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center database.
    Percik R; Liel Y; Urban D; Bar J; Ben-Ami E; Abu Tailakh M
    Acta Oncol; 2021 Nov; 60(11):1466-1471. PubMed ID: 34379562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.